| 37.10 |  +0.44 / +1.20% |
Data as of 4:03pm ET | Day’s Change |
| 37.07 |  -0.03 / -0.08% |
Volume: 104,000 |
| Abbott Stock To Go Ex-dividend Tomorrow (ABT) 10:54am / TheStreet.com | Stock Market News for April 3, 2013 - Market News Apr 03 / Zacks.com |
| Abbott Laboratories Stock Hold Recommendation Reiterated (ABT) Apr 08 / TheStreet.com | Stocks to Watch: Tesla, Verizon, Apple Apr 03 / TheStreet.com |
| Pharma & Biotech Stock Outlook - Apr 2013 - Industry Outlook Apr 04 / Zacks.com | Setback for Novartis in India - Analyst Blog Apr 02 / Zacks.com |
| Pharma & Biotech Stock Outlook - Apr 2013 - Zacks Analyst Interviews Apr 04 / Zacks.com | What Are the Opportunities Ahead for Abbott Labs Investors? Apr 02 / MotleyFool.com |
| Health Care's Elite Eight Stocks: Abbott Labs vs. Sanofi Apr 03 / MotleyFool.com | Why Mylan Is Poised to Keep Popping Apr 02 / MotleyFool.com |
| Previous close | 36.66 |
| Today’s open | 36.73 |
| Day’s range | 36.66 - 37.14 |
| Volume | 6,684,159 |
| Average volume (3 months) | 10,324,963 |
| Market cap | $57.6B |
| Dividend yield | 1.51% |
| Earnings growth (last year) | +23.59% |
| Earnings growth (this year) | -17.93% |
| Earnings growth (next 5 years) | +12.00% |
| Revenue growth (last year) | +2.63% |
| P/E ratio | 10.0 |
| Price/Sales | 2.59 |
| Price/Book | 2.16 |
| Today’s change | Today’s % change | |
|---|---|---|
| AZNAstraZeneca PLC | +0.42 | +0.83% |
| LLYEli Lilly and Co | +0.85 | +1.50% |
| CELGCelgene Corp | +4.20 | +3.60% |
| BMYBristol-Myers Squibb... | +0.36 | +0.88% |
| Next reporting date | April 17, 2013 |
| EPS forecast (this quarter) | $0.40 |
| Annual revenue (last year) | $39.9B |
| Annual profit (last year) | $6.0B |
| Net profit margin | 14.95% |
Sector Health Technology |
Industry Medical Specialties |
Chairman & Chief Executive Officer Miles D. White, MBA |
Chief Financial Officer & Executive Vice President Thomas C. Freyman, CPA |
Corporate headquarters Abbott Park, Illinois |
.
